We have another terrific episode of our Virtual Breakfast Series where we are joined by Michael Gilman. Michael is the CEO of Arrakis Therapeutics and has had an amazing career - with a scientific background that includes Cold Spring Harbor Laboratory and posts at ARIAD Pharmaceuticals and Biogen to leading startup companies like Arrakis, Padlock Therapeutics (acquired by BMS) and Stromedix (Acquired by Biogen) before Arrakis.